Search Results for 'catalent'

Contract Service Directory Companies

View All Buyers Guide Companies »

• Breaking News | cGMP Manufacture | Collaborations & Alliances | Drug Delivery | Facilities | Industry News | Solid Dosage/Semi-solids
  

  Catalent Acquires Acorda’s INBRIJA Manufacturing Operations

  The CDMO pays $80 million for dry powder inhaler spray drying, capsule manufacturing and packaging operations in Boston area.

  Contract Pharma Staff 01.13.21
  

  ---

• Aseptic Processing | Breaking News | Collaborations & Alliances | Parenterals
  

  Catalent Divests Blow-Fill-Seal Sterile CDMO Business

  SK Capital makes the acquisition; new independent company to be formed.

  Contract Pharma Staff 01.07.21
  

  ---

• Breaking News | cGMP Manufacture | Industry News
  

  Passage Bio, Catalent Begin cGMP Mfg. for Gene Therapies

  Completion of dedicated cGMP suite enhances manufacturing readiness and secures supply chain control to support lead CNS product candidates.

  Contract Pharma Staff 12.10.20
  

  ---

• Breaking News | Drug Development | Promotions & Moves
  

  Catalent Appoints Minakuchi Facility GM

  Nakaya “Nick” Matsumaru joins the company from SymBio Pharmaceuticals.

  Contract Pharma Staff 12.10.20
  

  ---

• Breaking News | cGMP Manufacture | Cytotoxics and High Potency Manufacturing | Industry News
  

  Catalent Invests $10M in Isolator Capabilities to Expand Micronization

  Will allow flexible jet milling ops to be carried out at sites in Malvern, PA and Dartford, U.K. under high containment.

  Contract Pharma Staff 12.04.20
  

  ---

• Breaking News | cGMP Manufacture | Industry News
  

  Catalent, Blueprint Enter GAVRETO Commercial Supply Pact

  Following FDA approval and tech transfer, the Catalent team in Kansas City will support commercial supply of the non-small cell lung cancer drug.

  Contract Pharma Staff 11.23.20
  

  ---

• Promotions & Moves
  

  Catalent Appoints Open Innovation, Biologics, Cell and Gene Therapy VP

  Behzad Mahdavi brings more than 20 years of experience in developing and implementing growth strategies in the biopharmaceutical industries.

  Contract Pharma Staff 11.19.20
  

  ---

• Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News
  

  Taysha Gene Therapies Partners with Catalent

  Rapidly expands Taysha’s manufacturing capacity.

  Contract Pharma Staff 11.05.20
  

  ---

• Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Industry News
  

  Catalent to Acquire Bone Therapeutics’ Cell Therapy Mfg. Facility

  Expands cell therapy capabilities and advanced clinical and commercial supply, and creates an integrated European CoE.

  Contract Pharma Staff 10.29.20
  

  ---

• Breaking News | Industry News
  

  Stevanato, Catalent Partner to Expedite Equipment Installation

  Stevanato’s high-speed visual inspection machines will support biologic and vaccine programs at Catalent manufacturing sites in U.S. and Italy.

  Contract Pharma Staff 10.27.20
  

  ---

• Breaking News | cGMP Manufacture | Clinical Trial Materials | Industry News | Scale-up/Technology Transfer
  

  Catalent, BrainStorm Enter ALS Drug Manufacturing Pact

  Catalent will undertake the transfer of the manufacturing process to, and provide future cGMP clinical supply of NurOwn from its Houston facility.

  Contract Pharma Staff 10.22.20
  

  ---

• Breaking News | cGMP Manufacture | Formulation Development | Industry News | Scale-up/Technology Transfer
  

  Catalent Launches OneXpress Solution

  Aims to accelerate a program’s transition from early-phase development to commercial-ready manufacturing for oral dosage products.

  Contract Pharma Staff 10.01.20
  

  ---

• Breaking News | cGMP Manufacture | Fill/Finish | Industry News
  

  Catalent Provides Mfg. Support for Nocion Program

  Manufactures clinical-scale batches of blow-fill-seal nebulizer ampules to treat cough in patients with COVID-19.

  Contract Pharma Staff 09.29.20
  

  ---

• Bio News | Biologics, Proteins, Vaccines | Breaking News | Facilities | Fill/Finish | Industry News
  

  Catalent Acquires New Biologics Facility

  Creates North American clinical manufacturing center of excellence.

  Contract Pharma Staff 09.24.20
  

  ---

• Breaking News | cGMP Manufacture | Clinical Trial Materials | Industry News | Scale-up/Technology Transfer
  

  T-knife, Catalent Sign Tech Transfer and Mfg. Pact for Cell Therapy

  Catalent to provide technology transfer and cGMP clinical manufacture of T-knife’s T1367 T-cell receptor program at its site in Gosselies, Belgium.

  Contract Pharma Staff 09.21.20
  

  ---

• Breaking News | Industry News
  

  Catalent to be Added to S&P 500 Index

  The CDMO will move from the S&P MidCap 400 to the S&P 500 on Sept. 21, 2020.

  Contract Pharma Staff 09.18.20
  

  ---

• Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Industry News
  

  Catalent Invests $130M in Harmans Gene Therapy Campus

  To add five additional Phase 3 through commercial-scale manufacturing suites to support growing market demand.

  Contract Pharma Staff 09.09.20
  

  ---

• Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Drug Development | Industry News
  

  Exelixis and Catalent Enter ADC Partnership

  Collaboration, license and exclusive option agreement to develop antibody-drug conjugates leveraging SMARTag bioconjugation technology.

  Contract Pharma Staff 09.08.20
  

  ---

• Breaking News | cGMP Manufacture | Clinical Trial Materials | Fill/Finish | Industry News
  

  Catalent Invests $50M at Bloomington Facility

  To install an additional high-speed vial filling line to support growing pipeline of clinical programs and commercial launches at the site.

  Contract Pharma Staff 09.02.20
  

  ---

• Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News
  

  Catalent and AstraZeneca Enter Vaccine Manufacturing Deal

  Expands manufacturing support for COVID-19 vaccine candidate AZD1222.

  Contract Pharma Staff 08.24.20
  

  ---

• Breaking News | cGMP Manufacture | Industry News
  

  Catalent’s Harmans Site Approved to Manufacture AveXis’ Gene Therapy

  To produce commercial drug substance intermediate for AveXis’ spinal muscular atrophy gene therapy at its manufacturing facility in Harmans, MD.

  Contract Pharma Staff 08.07.20
  

  ---

• Breaking News | cGMP Manufacture | Cytotoxics and High Potency Manufacturing | Industry News
  

  Catalent to Expand Argentinian Site in Buenos Aires

  Adding 11,000 sq.-ft. of production space segregated and designed to handle cytotoxic and highly active products for prescription softgel manufacturing.

  Contract Pharma Staff 08.04.20
  

  ---

• Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News
  

  Catalent Partners with Gene Editing Company Editas

  Will provide services for the development and manufacturing of Editas’ cell and gene medicines.

  Contract Pharma Staff 07.29.20
  

  ---

• Bio News | Breaking News | Clinical Trial Materials | Facilities | Industry News
  

  Catalent Expands Clinical Manufacturing Operations

  Invests $30 million to create European clinical manufacturing center of excellence in Limoges, France.

  Contract Pharma Staff 07.21.20
  

  ---

• Breaking News | cGMP Manufacture | Clinical Trial Materials | Drug Development | Industry News
  

  Catalent, Humanigen Expand Lenzilumab Services Pact

  Catalent will provide development, manufacturing and commercialization services for Humanigen’s GM-CSF monoclonal antibody being studied in COVID-19.

  Contract Pharma Staff 07.16.20
  

  ---

• Breaking News | Clinical Trial Materials | Industry News
  

  Catalent Completes Purchase of Teva-Takeda Packaging Facility

  The new 60,000-square-foot facility will provide flexible clinical supply solutions, serving both local and global pharma and biopharma companies.

  Contract Pharma Staff 07.01.20
  

  ---

• Breaking News | Industry News | Laboratory Testing
  

  Catalent Biologics Certified for PathHunter Assay Services

  Eurofins DiscoverX PathHunter assay platform performs highly reproducible potency lot release assays under GLP/GMP conditions.

  Contract Pharma Staff 06.29.20
  

  ---

• Breaking News | Industry News
  

  Moderna, Catalent Enter Commercial Fill-finish COVID-19 Vax Mfg. Pact

  Catalent will provide vial filling, packaging capacity and additional staffing for 24x7 manufacturing ops to support production of an initial 100 million doses.

  Contract Pharma Staff 06.25.20
  

  ---

• Breaking News | Collaborations & Alliances | Industry News
  

  Catalent Partners with ViralClear on Potential Treatment for COVID-19

  Catalent will be developing two oral dosage forms of ViralClear’s broad-spectrum anti-viral agent merimepodib.

  Contract Pharma Staff 06.22.20
  

  ---

• Biologics, Proteins, Vaccines | Breaking News | Facilities
  

  Optima Supports Catalent with High-Speed Vial Filling Line

  Prepares for large-scale commercial manufacturing of a lead vaccine candidate for COVID-19.

  Contract Pharma Staff 06.17.20
  

  ---

• Biologics, Proteins, Vaccines | Breaking News | Drug Development | Industry News
  

  Catalent, AstraZeneca Ink Mfg. Pact for COVID-19 Vax

  Catalent preparing for large-scale commercial supply of the University of Oxford’s COVID-19 vaccine candidate AZD1222 starting August 2020.

  Contract Pharma Staff 06.15.20
  

  ---

• Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News
  

  Catalent Enters COVID-19 Vax Pact with Spicona

  Will leverage GPEx cell line development platform to develop COVID-19 vaccine

  Contract Pharma Staff 06.10.20
  

  ---

• Breaking News | Industry News | Information Technology | Promotions & Moves
  

  Catalent Names Charles Lickfold as Chief Information Officer

  Succeeds John McGill who will retire in the fall

  Contract Pharma Staff 06.02.20
  

  ---

• Breaking News | cGMP Manufacture | Clinical Trial Materials | Industry News
  

  Catalent Acquires Clinical Packaging Facility in Japan

  Establishes a new clinical GMP manufacturing and distribution hub to support local and global clinical studies.

  Contract Pharma Staff 05.21.20
  

  ---

• Formulation Development | Industry News | Trials & Filings
  

  Triphase, Catalent Announce Interim TRPH-222 Results in NHL

  TRPH-222 leverages Catalent’s SMARTag platform to provide optimized site-specific protein-modification and linker technologies.

  Contract Pharma Staff 05.19.20
  

  ---

• Breaking News | Formulation Development | Industry News | Solid Dosage/Creams/Ointments
  

  Catalent, Ennaid Therapeutics Ink COVID-19 Program Pact

  Catalent will develop a powder-in-capsule formulation of Ennaid’s ENU200 program, a repurposed antiviral drug for the potential treatment of COVID-19

  Contract Pharma Staff 05.13.20
  

  ---

• Bio News | Breaking News | Clinical Trial Materials | Clinical Trials | Collaborations & Alliances | Industry News
  

  Catalent Provides Clinical Support for COVID-19 Study

  Partners with Humanigen for FDA-approved Phase 3 lenzilumab study for COVID-19 patients

  Contract Pharma Staff 05.08.20
  

  ---

• Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News
  

  Arcturus, Catalent Partner to Manufacture COVID-19 Vaccine

  The manufacture of LUNAR-COV19 at Catalent’s drug substance biomanufacturing facility in Madison, WI will support human clinical studies

  Contract Pharma Staff 05.04.20
  

  ---

• Breaking News | Promotions & Moves
  

  Catalent Appoints Cell & Gene Therapy President

  Manja Boerman will lead all of Catalent’s cell & gene therapy businesses worldwide.

  Contract Pharma Staff 05.01.20
  

  ---

• Breaking News | cGMP Manufacture | Industry News | Scale-up/Technology Transfer
  

  Catalent, J&J Enter Mfg. Pact for COVID-19 Vax Candidate

  Includes joint investment and tech transfer to prepare for rapid scale-up and cGMP commercial manufacturing at Catalent's Bloomington facility.

  Contract Pharma Staff 04.29.20
  

  ---

• Breaking News | cGMP Manufacture | Fill/Finish | Industry News
  

  Catalent Completes $14M Biologics Packaging Expansion

  Adds 15,000 square feet of packaging infrastructure to biologics and sterile manufacturing at its Bloomington, IN facility

  Contract Pharma Staff 04.23.20
  

  ---

• Drug Delivery
  

  CEO Spotlight: Will Downie

  Vectura’s chief executive talks trends in the inhaled-drug market, and the company’s transition into a CDMO

  Tim Wright, Editor, Contract Pharma 04.01.20
  

  ---

• Breaking News | Promotions & Moves
  

  Pii Appoints Sridhar Krishnan Ops SVP

  Krishnan brings more than 25 years of experience in global supply chain operations and quality

  03.23.20
  

  ---

• Breaking News | Formulation Development | Industry News
  

  Biohaven Wins FDA Approval for NURTEC ODT

  Developed in partnership with Catalent using its Zydis orally disintegrating tablet (ODT) technology

  03.17.20
  

  ---

• 

  Vectura Appoints Chief Commercial Officer

  Mark Bridgewater will focus on helping the company transform into a contract development and manufacturing organization.

  03.09.20
  

  ---

• Solid Dosage/Creams/Ointments
  

  Oral Solids Remain Robust

  Exploring trends in the oral solid dosage manufacturing market with some of today’s leading contract service providers.

  Tim Wright , Editor, Contract Pharma 03.04.20
  

  ---

• Solid Dosage/Creams/Ointments
  

  Oral Solids Remain Robust

  Exploring trends in the oral solid dosage manufacturing market with some of today’s leading contract service providers.

  Tim Wright, Editor, Contract Pharma 03.02.20
  

  ---

• Breaking News | cGMP Manufacture | Clinical Trial Materials | Industry News
  

  Catalent Supports Blueprint’s AYVAKIT Approval

  Nottingham UK facility to provide commercial supply of AYVAKIT

  02.27.20
  

  ---

• Breaking News | Industry News
  

  Perrigo, Catalent Win Approval for Generic Albuterol Aerosol

  Becomes the first generic Metered-Dose Inhaler to be approved by the FDA in more than twenty years

  02.25.20
  

  ---

• Breaking News | Promotions & Moves
  

  Catalent Appoints Ops VP for Specialty Delivery Biz

  Walter will have operational responsibility for five of the company’s facilities

  02.12.20
  

  ---